Metabolism of sumatriptan revisited

Abstract Scientific literature describes that sumatriptan is metabolized by oxidative deamination of its dimethylaminoethyl residue by monoamine oxidase A (MAO A) and not by cytochrome P450 (CYP)‐mediated demethylation, as is usual for such structural elements. Using recombinant human enzymes and HP...

Full description

Bibliographic Details
Main Authors: Timo Pöstges, Matthias Lehr
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.1051
_version_ 1811165291755864064
author Timo Pöstges
Matthias Lehr
author_facet Timo Pöstges
Matthias Lehr
author_sort Timo Pöstges
collection DOAJ
description Abstract Scientific literature describes that sumatriptan is metabolized by oxidative deamination of its dimethylaminoethyl residue by monoamine oxidase A (MAO A) and not by cytochrome P450 (CYP)‐mediated demethylation, as is usual for such structural elements. Using recombinant human enzymes and HPLC‐MS analysis, we found that CYP enzymes may also be involved in the metabolism of sumatriptan. The CYP1A2, CYP2C19, and CYP2D6 isoforms converted this drug into N‐desmethyl sumatriptan, which was further demethylated to N,N‐didesmethyl sumatriptan by CYP1A2 and CYP2D6. Otherwise, sumatriptan and its two desmethyl metabolites were metabolized by recombinant MAO A but not by MAO B to the corresponding acetaldehyde, with sumatriptan being only a poor substrate for MAO A compared to the N‐demethylated and the N,N‐didemethylated derivatives.
first_indexed 2024-04-10T15:34:53Z
format Article
id doaj.art-c6dd6de221714b1ab7f880556aafdcf4
institution Directory Open Access Journal
issn 2052-1707
language English
last_indexed 2024-04-10T15:34:53Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Pharmacology Research & Perspectives
spelling doaj.art-c6dd6de221714b1ab7f880556aafdcf42023-02-13T07:58:31ZengWileyPharmacology Research & Perspectives2052-17072023-02-01111n/an/a10.1002/prp2.1051Metabolism of sumatriptan revisitedTimo Pöstges0Matthias Lehr1Institute of Pharmaceutical and Medicinal Chemistry University of Münster Münster GermanyInstitute of Pharmaceutical and Medicinal Chemistry University of Münster Münster GermanyAbstract Scientific literature describes that sumatriptan is metabolized by oxidative deamination of its dimethylaminoethyl residue by monoamine oxidase A (MAO A) and not by cytochrome P450 (CYP)‐mediated demethylation, as is usual for such structural elements. Using recombinant human enzymes and HPLC‐MS analysis, we found that CYP enzymes may also be involved in the metabolism of sumatriptan. The CYP1A2, CYP2C19, and CYP2D6 isoforms converted this drug into N‐desmethyl sumatriptan, which was further demethylated to N,N‐didesmethyl sumatriptan by CYP1A2 and CYP2D6. Otherwise, sumatriptan and its two desmethyl metabolites were metabolized by recombinant MAO A but not by MAO B to the corresponding acetaldehyde, with sumatriptan being only a poor substrate for MAO A compared to the N‐demethylated and the N,N‐didemethylated derivatives.https://doi.org/10.1002/prp2.1051cytochrome P450metabolismmonoamine oxidasesumatriptanzolmitriptan
spellingShingle Timo Pöstges
Matthias Lehr
Metabolism of sumatriptan revisited
Pharmacology Research & Perspectives
cytochrome P450
metabolism
monoamine oxidase
sumatriptan
zolmitriptan
title Metabolism of sumatriptan revisited
title_full Metabolism of sumatriptan revisited
title_fullStr Metabolism of sumatriptan revisited
title_full_unstemmed Metabolism of sumatriptan revisited
title_short Metabolism of sumatriptan revisited
title_sort metabolism of sumatriptan revisited
topic cytochrome P450
metabolism
monoamine oxidase
sumatriptan
zolmitriptan
url https://doi.org/10.1002/prp2.1051
work_keys_str_mv AT timopostges metabolismofsumatriptanrevisited
AT matthiaslehr metabolismofsumatriptanrevisited